455
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2011
Study Completion Date
June 30, 2011
Neramexane mesylate
Double-blind treatment period of 29 weeks up to 75 mg Neramexane mesylate per day
Placebo
Double-blind treatment period of 29 weeks placebo
Clin Pharm International GmbH, Zentrum Wien, Vienna
A. ö. Krankenhaus der Elisabethinen Linz, Linz
Bezirkskrankenhaus Kufstein, Kufstein
Krankenhaus der Elisabethinen, Graz
Montefiore Medical Center, The Bronx
Klin. Forschung Berlin Buch GmbH, Berlin
Erie County Medical Center, Department of Rehabilitation Medicine; State University of New York at Buffalo, Buffalo
Health Research of Hampton Roads, Inc., Newport News
Piedmont Medical Research, Winston-Salem
Cary Medical Research, Cary
Wake Research Associates, LLC, Raleigh
Wilmington Medical Research, Wilmington
Medical University of South Carlolina, Otolaryngology, Charleston
Visions Clinical Research, Boynton Beach
Clinical Research of West Florida, Inc., Tampa
Tampa Bay Medical Research, Clearwater
Praxis im Schlosscarree, Braunschweig
Commonwealth Ear, Nose & Throat, Louisville
Dr. Werner Gieselmann, Heiligenhaus
Unidad de Investigación Clínica Cardiometábolica de Occidente S.C. (UNICAMO), Jalisco
Deaconess Clinic, Inc., Newburgh
Deaconess Clinic, Inc., Evansville
MediSphere Medical Research Center, LLC, Evansville
Dr. Wolfgang Lotte, Iserlohn
Glacier Ear, Nose, and Throat, Head and Neck Surgery, P.C., Kalispell
Deerpath Physicians Group, Gurnee
Knight Center for Integrated Health, Peoria
Dr. Klaus Peter Jayme, Darmstadt
Dr. Dannesberger, Lorsch
Heartland Research Associates, LLC., Wichita
Heartland Research Associates, LLC., Wichita
Research Across America, Plano
FutureSearch Trials of Dallas, Dallas
R/D Clinical Research, Inc., Lake Jackson
South Texas Research Alliance LLC, Laredo
"Hospital Central Dr. Ignacio Morones Prieto; Servicio de Otorrinolaringología", San Luis Potosí City
Austin Ear, Nose and Throat Clinic, Austin
Future Search Trials of Neurology, Austin
Unidad Médica de Especialidades del Noroeste (UMEN), Sinaloa
New West Physicians, Golden
Colorado Otolaryngology Associates, Colorado Springs
LMU München, Klinikum Großhadern, München
Advanced Clinical Research, West Jordon
Phoenix Clinical, Phoenix
Horizon Clinical Research Associates PLLC, Gilbert
Paradigm Clinical Research, Tucson
Dr. Susanne Wiedemann, Nuremberg
Providence Clinical Research, Burbank
Central California Clinical Research, Fresno
UC Davis Health System, Sacramento
HNO Praxis, Bamberger Str. 7, Lichtenfels
University of Iowa Hospitals & Clinics, Iowa City
University of Kansas; Department of Otolaryngology Head & Neck Surgery, Kansas City
Immedicenter, Bloomfield
David L. Bortniker, Somerville
Consultório Dr. Marcelo Rates, Belo Horizonte
Instituto de Otorrinolaringologia Linhares, Rio de Janeiro
Faculdade de Medicina do ABC, Santo André/SP
Universidade Federal de São Paulo - UNIFESP, Sao Paulo/ SP
Clínica OTOSUL, Valença
Hospital de Clinicas de Porto Alegre, Rio Grande
Instituto Ganz Sanchez, São Paulo/SP
Dr. Christian Dörr, Dresden
Dr. Elisabeth Kühne, Halle
ClinPharm International GmbH, Leipzig
Instituto Biomédico de Investigación A.C., Aguascalientes
Hospital General de Chihuahua, Chihuahua City
Hospital Christus Muguerza del Parque, Chihuahua City
Clinical Research Instutute S.C., Edo. de México
"Hospital Civil de Guadalajara Fray Antonio Alcalde, Servicio de Otorrinolaringología; Hospital No. 278", Guadalajara Jalisco
Grupo Médico Terranova, Guadalajara Jalisco
Hospital General de México S.S. O.D.; Servicio de Otorrinolaringología, México D.F.
Hospital OCA Monterrey International Research Center (MIRC), Nuevo León
Hospital Universitario, Nuevo León
Unidad de Tratamientos Avanzados (UTRAV) S.C., Nuevo León
Medicentro del Parque, San Luis Potosí City
Lead Sponsor
Merz Pharmaceuticals GmbH
INDUSTRY